细胞株Cell Lines 59及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV59
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID HSM-2
AC CVCL_M512
RX PubMed=2064960;
RX PubMed=10936422;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HSM-2.3
AC CVCL_M513
RX PubMed=2064960;
RX PubMed=10936422;
CC Characteristics: IL3 or IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M512 ! HSM-2
SX Male
CA Cancer cell line
//
ID HSmC-78
AC CVCL_M122
SY HSmC 78; HSmC78
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=548013;
RX PubMed=6837290;
DI NCIt; C5943; Submandibular gland squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HSME6o-
AC CVCL_IN67
RX PubMed=15463957;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HSME82o-
AC CVCL_IN68
RX PubMed=15463957;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HSNB
AC CVCL_L554
DR CLO; CLO_0051414
DR BioSample; SAMN03472270
DR RCB; RCB0666
RX PubMed=2486666;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12,14
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 10,12
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HSNT1
AC CVCL_K096
DR RCB; AES0128
DR RCB; RCB2702
CC Discontinued: RCB; RCB2702; true.
CC Breed/subspecies: C57BL/6 x 129.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID HSNT2
AC CVCL_K097
DR RCB; AES0129
DR RCB; RCB2703
CC Discontinued: RCB; RCB2703; true.
CC Breed/subspecies: C57BL/6 x 129.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID HSOGT
AC CVCL_6655
RX PubMed=15005243;
DI NCIt; C6261; Ovarian granulosa cell tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HSP-239
AC CVCL_2518
DR CLO; CLO_0050225
DR JCRB; JCRB1165
DR RCB; RCB1854
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Transformed cell line
//
ID HSP-250
AC CVCL_2519
DR CLO; CLO_0050224
DR JCRB; JCRB1177
DR RCB; RCB1855
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Female
CA Transformed cell line
//
ID HSP00332IN
AC CVCL_E163
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9581; ! Hylobates sp.
SX Sex undetermined
CA Transformed cell line
//
ID HSQ-89
AC CVCL_7674
SY HSQ89
DR CLO; CLO_0050085
DR BioSample; SAMN03472238
DR GEO; GSM850385
DR RCB; RCB0789
RX PubMed=14733907;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 12,13
ST TH01: 7,9.3
ST TPOX: 11,12
ST vWA: 14,20
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HSR-1
AC CVCL_9Q49
RX PubMed=8610465;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
OX NCBI_TaxID=9544; ! Macaca mulatta
CA Transformed cell line
//
ID HSR-4
AC CVCL_EG68
DR JCRB; JCRB1641
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
OX NCBI_TaxID=9544; ! Macaca mulatta
CA Transformed cell line
//
ID HSR-5
AC CVCL_2952
DR JCRB; JCRB1211
RX PubMed=8610465;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
OX NCBI_TaxID=9544; ! Macaca mulatta
CA Transformed cell line
//
ID HSR-GBM1A
AC CVCL_DI57
SY HSR-GBM1a; HSR GBM1A; GBM 0913; 0913; 020913; 20913
RX PubMed=15466194;
RX PubMed=22380883;
CC Group: Cancer stem cell line.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HSR-GBM1B
AC CVCL_DI58
SY GBM 0627; 0627; 010627; 10627
DR GEO; GSM481415
RX PubMed=15466194;
RX PubMed=22380883;
CC Group: Cancer stem cell line.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HSS-84
AC CVCL_N592
RX PubMed=2851424;
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HST-1
AC CVCL_E316
SY HST-I
RX PubMed=2759736;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HST2
AC CVCL_T740
SY HST-2
RX PubMed=8391386;
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HSV33
AC CVCL_G033
DR IMGT/HLA; 12983
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HSV48
AC CVCL_G034
DR IMGT/HLA; 13095
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HSY
AC CVCL_B032
DR BioSample; SAMN03151716
DR BioSample; SAMN03471294
DR Cosmic; 974318
DR JCRB; CHB0001
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: JCRB; CHB0001; probable.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D5S818: 11
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HSY-EB
AC CVCL_U462
RX PubMed=11997388;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-513.html
CC Problematic cell line: Probably contaminated. Parent cell line (HSY) has been shown to be a HeLa derivative.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B032 ! HSY
SX Female
CA Cancer cell line
//
ID HT
AC CVCL_1290
DR CLO; CLO_0004265
DR EFO; EFO_0002200
DR ATCC; CRL-2260
DR BCRC; 60486
DR BioSample; SAMN01821562
DR BioSample; SAMN01821633
DR BioSample; SAMN03472827
DR BioSample; SAMN03473482
DR CCLE; HT_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308143
DR ChEMBL-Targets; CHEMBL2366130
DR Cosmic; 687844
DR Cosmic; 907063
DR Cosmic; 1067441
DR Cosmic; 1541915
DR Cosmic; 1945181
DR Cosmic; 2022501
DR Cosmic; 2276317
DR Cosmic-CLP; 907063
DR DSMZ; ACC-567
DR GDSC; 907063
DR GEO; GSM380127
DR GEO; GSM552431
DR GEO; GSM887143
DR GEO; GSM888215
DR GEO; GSM1059806
DR GEO; GSM1151288
DR GEO; GSM1374558
DR GEO; GSM1669907
DR IGRhCellID; HT
RX PubMed=2313723;
RX PubMed=19278952;
RX PubMed=19358282;
RX PubMed=22460905;
RX PubMed=23292937;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~30-40 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 13,14
ST D16S539: 11,13
ST D18S51: 12,19
ST D21S11: 29,31.2
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 8,10 (ATCC; Cosmic-CLP; PubMed=25877200)
ST D7S820: 7.3,8,10 (DSMZ)
ST D8S1179: 10,13
ST FGA: 21,22.2
ST Penta D: 13
ST Penta E: 10,20
ST TH01: 6,7
ST TPOX: 11
ST vWA: 17,18 (ATCC; DSMZ; PubMed=25877200)
ST vWA: 17,18,19 (Cosmic-CLP)
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HT [Human ovarian serous cystadenocarcinoma]
AC CVCL_Y005
DR CGH-DB; 324-2
RX PubMed=17671176;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HT 29/15
AC CVCL_J689
SY HT 29-15; HT29/15
DR ATCC; HB-8246
RX Patent=US4579827;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID HT 29/26
AC CVCL_J690
SY SKI 294/HT 29/26; SKI294/HT29/26; HT 29-26; HT29/26; C26
DR CLO; CLO_0004270
DR ATCC; HB-8247
RX Patent=US4579827;
RX Patent=US4935344;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID HT 29/36
AC CVCL_J691
SY SKI 294/HT 29/36; SKI294/HT29/36; HT 29-36; HT29/36; H 29-36
DR CLO; CLO_0004271
DR ATCC; HB-8248
RX Patent=US4579827;
RX Patent=US5168043;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID HT 709A
AC CVCL_U689
SY XPKFSF
DR ATCC; CRL-1206
CC Discontinued: ATCC; CRL-1206; true.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HT-1 [Hamster]
AC CVCL_Y446
DR ATCC; CRL-6283
RX PubMed=5230142;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC Discontinued: ATCC; CRL-6283; true.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Sex undetermined
CA Cancer cell line
//
ID HT-1 [Human lymphoma]
AC CVCL_5T93
RX PubMed=1310890;
DI NCIt; C7226; Adult T lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HT-1080
AC CVCL_0317
SY Ht-1080; HT 1080; HT1080; HT 1080.T
DR BTO; BTO:0001282
DR CLO; CLO_0004266
DR CLO; CLO_0004276
DR EFO; EFO_0002059
DR MCCL; MCC:0000210
DR CLDB; cl1735
DR CLDB; cl1736
DR CLDB; cl1737
DR CLDB; cl1738
DR CLDB; cl1740
DR CLDB; cl1741
DR CLDB; cl1742
DR CLDB; cl4913
DR ATCC; CCL-121
DR ATCC; CRL-7951
DR BCRC; 60037
DR BCRJ; 0110
DR BioSample; SAMN01821563
DR BioSample; SAMN01821634
DR BioSample; SAMN01821685
DR BioSample; SAMN01821731
DR BioSample; SAMN03471913
DR CCLE; HT1080_SOFT_TISSUE
DR CCRID; 3111C0001CCC000070
DR CCRID; 3142C0001000000116
DR ChEMBL-Cells; CHEMBL3308396
DR ChEMBL-Targets; CHEMBL614580
DR CLS; 300216/p517_HT-1080
DR Cosmic; 716177
DR Cosmic; 716188
DR Cosmic; 724819
DR Cosmic; 907064
DR Cosmic; 912000
DR Cosmic; 1045409
DR Cosmic; 1067221
DR Cosmic; 1933190
DR Cosmic; 2009505
DR Cosmic; 2301553
DR Cosmic; 2307731
DR Cosmic-CLP; 907064
DR DSMZ; ACC-315
DR ECACC; 85111505
DR ENCODE; ENCBS039VHD
DR ENCODE; ENCBS225AAA
DR ENCODE; ENCBS512AAA
DR ENCODE; ENCBS513AAA
DR ENCODE; ENCBS617SGR
DR ENCODE; ENCBS688VJF
DR ENCODE; ENCBS798NML
DR ENCODE; ENCBS816VMN
DR ENCODE; ENCBS937RAY
DR GDSC; 907064
DR GEO; GSM185089
DR GEO; GSM185090
DR GEO; GSM256074
DR GEO; GSM256075
DR GEO; GSM256076
DR GEO; GSM256077
DR GEO; GSM256078
DR GEO; GSM256079
DR GEO; GSM256080
DR GEO; GSM256081
DR GEO; GSM256082
DR GEO; GSM256083
DR GEO; GSM256084
DR GEO; GSM256085
DR GEO; GSM256086
DR GEO; GSM256087
DR GEO; GSM256088
DR GEO; GSM256089
DR GEO; GSM256090
DR GEO; GSM256091
DR GEO; GSM256092
DR GEO; GSM256093
DR GEO; GSM256094
DR GEO; GSM256095
DR GEO; GSM256096
DR GEO; GSM256097
DR GEO; GSM256098
DR GEO; GSM256099
DR GEO; GSM256100
DR GEO; GSM256101
DR GEO; GSM256102
DR GEO; GSM256103
DR GEO; GSM256104
DR GEO; GSM256105
DR GEO; GSM256106
DR GEO; GSM256107
DR GEO; GSM256108
DR GEO; GSM256109
DR GEO; GSM256110
DR GEO; GSM256111
DR GEO; GSM256112
DR GEO; GSM256113
DR GEO; GSM256114
DR GEO; GSM827307
DR GEO; GSM887136
DR GEO; GSM888207
DR GEO; GSM1669908
DR GEO; GSM1676302
DR GEO; GSM1701637
DR ICLC; HTL98016
DR IFO; IFO50354
DR IGRhCellID; HT1080
DR IZSLER; BS TCL 27
DR JCRB; JCRB9113
DR KCB; KCB 2013029YJ
DR KCLB; 10121
DR Lonza; 744
DR NCBI_Iran; C437
DR RCB; RCB1956
DR TOKU-E; 1963
DR Wikidata; Q5636047
RX PubMed=3413074;
RX PubMed=3558490;
RX PubMed=4132053;
RX PubMed=6652615;
RX PubMed=17254797;
RX PubMed=22460905;
RX PubMed=24726063;
RX PubMed=25485619;
RX PubMed=26351324;
RX PubMed=26368816;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/HT1080
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-124.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7951; true.
CC Discontinued: RCB; RCB1956; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; PubMed=11416159; PubMed=17254797; PubMed=25877200; RCB
ST Amelogenin: X,Y
ST CSF1PO: 12 (ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; PubMed=25877200; RCB)
ST CSF1PO: 11 (PubMed=17254797)
ST D13S317: 12,14
ST D16S539: 9,12
ST D18S51: 12,18
ST D21S11: 28,30
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 22,25
ST Penta D: 9,12
ST Penta E: 5,15
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HT-1080 NucLight Green
AC CVCL_DF43
WW http://www.essenbioscience.com/essen-products/reagents-and-consumables/ht-1080-nuclight-green-cells/
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
CC Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID HT-1080 NucLight Red
AC CVCL_DF44
WW http://www.essenbioscience.com/essen-products/reagents-and-consumables/ht-1080-nuclight-red-cells/
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
CC Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC Transfected with: mKate2; a bright red fluorescent protein derived from eqFP578.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID HT-1080 Tet-Off
AC CVCL_V355
SY Tet-off HT-1080
DR TOKU-E; 3749
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-Off_Cell_Lines
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID HT-1197
AC CVCL_1291
SY HT 1197; HT1197; HT 1197.T
DR BTO; BTO:0004124
DR CLO; CLO_0004267
DR CLO; CLO_0004278
DR EFO; EFO_0002202
DR CLDB; cl1734
DR CLDB; cl7161
DR ATCC; CRL-1473
DR ATCC; CRL-7926
DR BCRC; 60059
DR BioSample; SAMN03471362
DR CCLE; HT1197_URINARY_TRACT
DR ChEMBL-Cells; CHEMBL3308506
DR ChEMBL-Targets; CHEMBL614836
DR Cosmic; 715772
DR Cosmic; 760473
DR Cosmic; 845563
DR Cosmic; 907065
DR Cosmic; 925822
DR Cosmic; 928814
DR Cosmic; 1285117
DR Cosmic; 1285988
DR Cosmic; 1927306
DR Cosmic; 2037946
DR Cosmic; 2050443
DR Cosmic; 2057448
DR Cosmic; 2444236
DR Cosmic-CLP; 907065
DR ECACC; 87032403
DR GDSC; 907065
DR GEO; GSM142304
DR GEO; GSM827290
DR GEO; GSM887138
DR GEO; GSM888209
DR GEO; GSM1374559
DR GEO; GSM1669910
DR ICLC; HTL04006
DR IGRhCellID; HT1197
DR KCLB; 21473
DR SKY/M-FISH/CGH; 1463
RX PubMed=191628;
RX PubMed=3708594;
RX PubMed=6244232;
RX PubMed=8873383;
RX PubMed=22460905;
RX PubMed=23401075;
RX PubMed=24018021;
RX PubMed=24367658;
RX PubMed=25984343;
RX PubMed=25997541;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: 46 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7926; true.
ST Source(s): ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=11416159
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 19
ST D21S11: 31,32.2
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 9,13
ST FGA: 20,23
ST TH01: 6,9.3
ST TPOX: 11,12
ST vWA: 16,18
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HT-1376
AC CVCL_1292
SY HT1376; HT 1376; HT 1376.T
DR BTO; BTO:0003461
DR CLO; CLO_0004268
DR CLO; CLO_0004279
DR EFO; EFO_0002203
DR CLDB; cl1743
DR CLDB; cl1744
DR ATCC; CRL-1472
DR ATCC; CRL-7927
DR BCRC; 60058
DR BioSample; SAMN01821564
DR BioSample; SAMN01821635
DR BioSample; SAMN03472820
DR CCLE; HT1376_URINARY_TRACT
DR ChEMBL-Cells; CHEMBL3308398
DR ChEMBL-Targets; CHEMBL612258
DR Cosmic; 715761
DR Cosmic; 760481
DR Cosmic; 845562
DR Cosmic; 907066
DR Cosmic; 925821
DR Cosmic; 928815
DR Cosmic; 943733
DR Cosmic; 1046691
DR Cosmic; 1285118
DR Cosmic; 1285987
DR Cosmic; 1927303
DR Cosmic; 2050444
DR Cosmic; 2057449
DR Cosmic; 2444252
DR Cosmic-CLP; 907066
DR DSMZ; ACC-397
DR ECACC; 87032402
DR GDSC; 907066
DR GEO; GSM142305
DR GEO; GSM142310
DR GEO; GSM827432
DR GEO; GSM887139
DR GEO; GSM888210
DR GEO; GSM1374560
DR GEO; GSM1574553
DR GEO; GSM1669911
DR IGRhCellID; HT1376
DR IZSLER; BS TCL 70
DR KCLB; 21472
RX PubMed=191628;
RX PubMed=3708594;
RX PubMed=6244232;
RX PubMed=8873383;
RX PubMed=22460905;
RX PubMed=23401075;
RX PubMed=24367658;
RX PubMed=25997541;
RX PubMed=27397505;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: ~60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7927; true.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 11,14
ST D18S51: 14,15
ST D21S11: 26,32.2
ST D3S1358: 14,17
ST D5S818: 11,12
ST D7S820: 9,12
ST D8S1179: 14,16
ST FGA: 21,22
ST TH01: 7,10 (ATCC; Cosmic-CLP; DSMZ; ECACC)
ST TH01: 7,9.3 (KCLB; PubMed=11416159)
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HT-1417
AC CVCL_3523
SY HT 1417
DR CLO; CLO_0004269
DR ATCC; CRL-7797
DR BioSample; SAMN03471155
RX PubMed=6500159;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 18,19
DI NCIt; C3208; Lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HT-144
AC CVCL_0318
SY HT 144; HT144; HT144-mel; HT144mel
DR BTO; BTO:0001406
DR CLO; CLO_0004280
DR EFO; EFO_0006443
DR MCCL; MCC:0000211
DR ATCC; HTB-63
DR BioSample; SAMN03472749
DR CCLE; HT144_SKIN
DR CGH-DB; 9314-4
DR ChEMBL-Cells; CHEMBL3308870
DR ChEMBL-Targets; CHEMBL2366291
DR Cosmic; 687436
DR Cosmic; 889003
DR Cosmic; 905227
DR Cosmic; 907067
DR Cosmic; 928717
DR Cosmic; 929192
DR Cosmic; 932999
DR Cosmic; 1022276
DR Cosmic; 1028800
DR Cosmic; 1102379
DR Cosmic; 1155271
DR Cosmic; 1477411
DR Cosmic; 2159445
DR Cosmic-CLP; 907067
DR GDSC; 907067
DR GEO; GSM162902
DR GEO; GSM219028
DR GEO; GSM887140
DR GEO; GSM888211
DR GEO; GSM1669912
DR PRIDE; PXD002192
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=10338330;
RX PubMed=14692828;
RX PubMed=15048078;
RX PubMed=15467732;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=21654344;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://faculty.washington.edu/trawets/archive/Human/skin/ht144/index.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/ht-144-human-melanoma-cell-line
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-544.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'HT-114' in Cosmic 929192.
CC Derived from metastatic site: Subcutaneous.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HT-17
AC CVCL_B408
SY HT17
DR Cosmic; 1187340
DR Cosmic; 1571787
DR TKG; TKG 0203
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HT-2
AC CVCL_5T92
SY HT2
RX PubMed=92524;
RX PubMed=2953804;
RX PubMed=3100639;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HT-2
CC Characteristics: IL2 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID HT-2 clone A5E
AC CVCL_0319
SY HT2 Clone A5E
DR CLO; CLO_0004281
DR CLO; CLO_0004282
DR MCCL; MCC:0000212
DR CLDB; cl1745
DR ATCC; CRL-1841
DR ECACC; 92021401
CC Characteristics: IL2 and IL4 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5T92 ! HT-2
CA Factor-dependent cell line
//
ID HT-29
AC CVCL_0320
SY HT 29; HT29
DR BTO; BTO:0000182
DR CLO; CLO_0004283
DR EFO; EFO_0001193
DR MCCL; MCC:0000213
DR CLDB; cl1747
DR CLDB; cl1748
DR CLDB; cl1749
DR CLDB; cl1751
DR CLDB; cl1752
DR CLDB; cl1753
DR CLDB; cl1754
DR CLDB; cl4978
DR CLDB; cl5205
DR ATCC; HTB-38
DR BCRJ; 0111
DR BioSample; SAMN01821565
DR BioSample; SAMN03470953
DR CCLE; HT29_LARGE_INTESTINE
DR CCLV; CCLV-RIE 0960
DR CCRID; 3111C0001CCC000109
DR CCRID; 3131C0001000700103
DR CCRID; 3142C0001000000135
DR CCRID; 3153C0001000000017
DR ChEMBL-Cells; CHEMBL3307768
DR ChEMBL-Targets; CHEMBL384
DR CLS; 300215/p818_HT-29
DR Cosmic; 685867
DR Cosmic; 711273
DR Cosmic; 720331
DR Cosmic; 738929
DR Cosmic; 755308
DR Cosmic; 875295
DR Cosmic; 875898
DR Cosmic; 876716
DR Cosmic; 887217
DR Cosmic; 889523
DR Cosmic; 897459
DR Cosmic; 902789
DR Cosmic; 905939
DR Cosmic; 913891
DR Cosmic; 934562
DR Cosmic; 948132
DR Cosmic; 974246
DR Cosmic; 983739
DR Cosmic; 995412
DR Cosmic; 1043817
DR Cosmic; 1045405
DR Cosmic; 1057765
DR Cosmic; 1067225
DR Cosmic; 1071887
DR Cosmic; 1092605
DR Cosmic; 1122326
DR Cosmic; 1132575
DR Cosmic; 1154652
DR Cosmic; 1175842
DR Cosmic; 1176613
DR Cosmic; 1184093
DR Cosmic; 1184326
DR Cosmic; 1223142
DR Cosmic; 1248331
DR Cosmic; 1295658
DR Cosmic; 1299294
DR Cosmic; 1305355
DR Cosmic; 1310947
DR Cosmic; 1312339
DR Cosmic; 1436019
DR Cosmic; 1466816
DR Cosmic; 1479609
DR Cosmic; 1481417
DR Cosmic; 1482521
DR Cosmic; 1524327
DR Cosmic; 1537489
DR Cosmic; 1571769
DR Cosmic; 1609503
DR Cosmic; 1676733
DR Cosmic; 1708406
DR Cosmic; 1803945
DR Cosmic; 1888955
DR Cosmic; 1889160
DR Cosmic; 1933016
DR Cosmic; 1945866
DR Cosmic; 1995448
DR Cosmic; 1998447
DR Cosmic; 2052596
DR Cosmic; 2036654
DR Cosmic; 2145575
DR Cosmic; 2156939
DR Cosmic; 2301545
DR Cosmic; 2301988
DR Cosmic; 2433757
DR Cosmic; 2550354
DR Cosmic-CLP; 905939
DR DSMZ; ACC-299
DR ECACC; 91072201
DR ENCODE; ENCBS604AAA
DR ENCODE; ENCBS605AAA
DR ENCODE; ENCBS668UDT
DR ENCODE; ENCBS914HXH
DR GDSC; 905939
DR GEO; GSM811
DR GEO; GSM50190
DR GEO; GSM50254
DR GEO; GSM206503
DR GEO; GSM288491
DR GEO; GSM288497
DR GEO; GSM288499
DR GEO; GSM513815
DR GEO; GSM514295
DR GEO; GSM736967
DR GEO; GSM741261
DR GEO; GSM799333
DR GEO; GSM799396
DR GEO; GSM827150
DR GEO; GSM887141
DR GEO; GSM888212
DR GEO; GSM1153403
DR GEO; GSM1181252
DR GEO; GSM1181366
DR GEO; GSM1346844
DR GEO; GSM1374561
DR GEO; GSM1374562
DR GEO; GSM1374563
DR GEO; GSM1374564
DR GEO; GSM1448179
DR GEO; GSM1669913
DR ICLC; HTL99026
DR IZSLER; BS TCL 132
DR KCB; KCB 200508YJ
DR KCLB; 30038
DR Lonza; 430
DR MeSH; D019073
DR NCBI_Iran; C466
DR PRIDE; PRD000369
DR PRIDE; PRD000414
DR PRIDE; PXD001271
DR PRIDE; PXD003623
DR SKY/M-FISH/CGH; 1435
DR SKY/M-FISH/CGH; 2124
DR SKY/M-FISH/CGH; 2836
DR TOKU-E; 1968
DR Wikidata; Q28334700
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=864752;
RX PubMed=1389533;
RX PubMed=1778766;
RX PubMed=2041050;
RX PubMed=3349466;
RX PubMed=6500159;
RX PubMed=6582512;
RX PubMed=7459858;
RX PubMed=8895552;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=10612807;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=11921276;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19927377;
RX PubMed=19941903;
RX PubMed=20606684;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=22940288;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=26537799;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=15
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/HT29.html
WW http://www.addexbio.com/productdetail?pid=48
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-32.html
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-colorectal-adenocarcinoma-cell-line-ht-29
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 809.
CC Doubling time: 24 hours (PubMed=25984343); 19.5 hours (DTP); ~40-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'HCT29' in GEO GSM206503.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=11416159; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12 (ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=19372543; PubMed=25877200)
ST D13S317: 11 (CLS)
ST D16S539: 11,12
ST D18S51: 13
ST D19S433: 14
ST D21S11: 29,30
ST D2S1338: 19,23
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 10 (CLS; PubMed=19372543; PubMed=25877200)
ST D8S1179: 10,16 (PubMed=11416159)
ST FGA: 20,22
ST Penta D: 11,13
ST Penta E: 14,16
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HT-29 BR100
AC CVCL_DH88
SY HT29 BR100; BR100
DR GEO; GSM736968
RX PubMed=22216088;
CC Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29 BR200
AC CVCL_DH89
SY HT29 BR200; BR200
DR GEO; GSM736969
RX PubMed=22216088;
CC Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29 BR300
AC CVCL_DH90
SY HT29 BR300; BR300
DR GEO; GSM736970
CC Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29-D4
AC CVCL_8118
SY HT 29-D4; HT29-D4
DR Lonza; 371
RX PubMed=2736330;
RX PubMed=3543033;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29-D9
AC CVCL_4Z22
SY HT 29-D9; HT29-D9
RX PubMed=3543033;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29-G
AC CVCL_6833
SY HT-29 G; HT29G
DR BTO; BTO:0001566
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29-Luc
AC CVCL_J256
DR JCRB; JCRB1383
DR JCRB; NIHS0646
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0646; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29-luc-D6
AC CVCL_5J34
RX PubMed=14713107;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: PerkinElmer; Catalog number 119264.
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29-M6
AC CVCL_G077
SY HT-29 M6; HT29-M6; 5M6
RX PubMed=9579576;
RX PubMed=17311291;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29-MTX
AC CVCL_6834
SY HT-29 MTX; HT29-MTX
DR BTO; BTO:0001565
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29-MTX-E12
AC CVCL_G356
SY HT29-MTX-E12; MTX-E12
DR ECACC; 12040401
RX PubMed=11587485;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6834 ! HT-29-MTX
SX Female
CA Cancer cell line
//
ID HT-29-Red-FLuc
AC CVCL_5J00
SY HT29-Red-FLuc; HT29 Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW124353
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29/5-FU
AC CVCL_0I27
RX PubMed=25744837;
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29/5-FU/S
AC CVCL_0T66
RX PubMed=9600127;
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29/ADM
AC CVCL_Y178
DR CGH-DB; 9105-4
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29/cDDP
AC CVCL_Y177
SY HT/DDP
DR CGH-DB; 9104-4
RX PubMed=9816187;
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29/cl.f8
AC CVCL_DE12
SY HT-29 cl.F8; HT29.f8; HT29.F8
RX PubMed=15780006;
CC Characteristics: Spontaneously polarizing cell line.
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29/CPT
AC CVCL_H269
SY HT-29 / CPT
DR CGH-DB; 9103-4
RX PubMed=2170010;
RX PubMed=2174738;
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29/ETP
AC CVCL_Y179
DR CGH-DB; 9106-4
RX PubMed=14973057;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-295.T
AC CVCL_N341
SY HT 295.T
DR ATCC; CRL-7781
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7781; true.
DI NCIt; C2921; Skin basal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HT-297.T
AC CVCL_6404
SY HT 297.T
DR CLO; CLO_0004272
DR ATCC; CRL-7782
DR BioSample; SAMN03471154
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 9,12
ST D5S818: 9,12
ST D7S820: 8,9
ST TH01: 6
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HT-29R
AC CVCL_EQ49
DR Cosmic; 1889159
RX PubMed=21705440;
CC Selected for resistance to: ChEBI; CHEBI:132984; RO4927350.
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-29R13
AC CVCL_4V27
RX PubMed=7903534;
RX PubMed=8324877;
CC Selected for resistance to: ChEBI; CHEBI:27504; Mitomycin C (MMC).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT-3
AC CVCL_1293
SY HT3
DR CLO; CLO_0004286
DR EFO; EFO_0002204
DR ATCC; HTB-32
DR BioSample; SAMN03472916
DR ChEMBL-Cells; CHEMBL3308745
DR ChEMBL-Targets; CHEMBL1075470
DR Cosmic; 760222
DR Cosmic; 809227
DR Cosmic; 846183
DR Cosmic; 907068
DR Cosmic; 925353
DR Cosmic; 928908
DR Cosmic; 1131521
DR Cosmic; 1193036
DR Cosmic; 1201774
DR Cosmic; 1995449
DR Cosmic; 2301540
DR Cosmic-CLP; 907068
DR GDSC; 907068
DR GEO; GSM253299
DR GEO; GSM675735
DR GEO; GSM685442
DR GEO; GSM1669914
DR IGRhCellID; HT3
RX DOI=10.1007/978-1-4757-1647-4_5;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1648218;
RX PubMed=2990217;
RX PubMed=7459858;
RX PubMed=15531914;
RX PubMed=27397505;
WW https://www.mskcc.org/research-advantage/support/technology/tangible-material/ht-3-human-cervical-cell-line
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 784-01.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 15
ST D19S433: 14
ST D21S11: 29
ST D2S1338: 21
ST D3S1358: 15
ST D5S818: 10,13
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 21,22
ST Penta D: 12
ST Penta E: 11,12
ST TH01: 6,7
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C9039; Cervical carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HT-55
AC CVCL_1294
SY HT55
DR CLO; CLO_0004287
DR EFO; EFO_0006444
DR CLDB; cl1759
DR BioSample; SAMN03470915
DR BioSample; SAMN03473195
DR CCLE; HT55_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308746
DR ChEMBL-Targets; CHEMBL1075471
DR Cosmic; 907287
DR Cosmic; 948835
DR Cosmic; 995386
DR Cosmic; 1223143
DR Cosmic; 1803946
DR Cosmic; 2301989
DR Cosmic-CLP; 907287
DR ECACC; 85061105
DR GDSC; 907287
DR GEO; GSM206514
DR GEO; GSM827369
DR GEO; GSM887142
DR GEO; GSM888213
DR GEO; GSM1346845
DR GEO; GSM1448082
DR GEO; GSM1669915
RX PubMed=10737795;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HT55
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 28 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,13
ST D16S539: 14
ST D18S51: 13
ST D21S11: 28
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 11,14
ST FGA: 24
ST Penta D: 11
ST Penta E: 7,8
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HT-728.T
AC CVCL_3524
SY HT 728.T; HT-728-T; HT728T
DR CLO; CLO_0004273
DR ATCC; CRL-7783
DR Cosmic; 687929
DR GEO; GSM827463
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7783; true.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HT-738.T
AC CVCL_N465
SY HT 738.T
DR ATCC; CRL-7784
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7784; true.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HT-755.Mg
AC CVCL_S254
SY HT 755.Mg
DR ATCC; CRL-7785
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7785; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HT-756.Lu
AC CVCL_N461
SY HT 756.Lu
DR ATCC; CRL-7786
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7786; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N462 ! HT-756.T
SX Female
CA Finite cell line
//
ID HT-756.T
AC CVCL_N462
SY HT 756.T
DR ATCC; CRL-7787
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7787; true.
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N461 ! HT-756.Lu
SX Female
CA Cancer cell line
//
ID HT-758.Sk
AC CVCL_N463
SY HT 758.Sk
DR ATCC; CRL-7788
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7788; true.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HT-762.T
AC CVCL_3525
SY HT 762.T
DR CLO; CLO_0004274
DR ATCC; CRL-7789
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7789; true.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HT-768.M
AC CVCL_6405
SY HT 768.M
DR CLO; CLO_0004275
DR ATCC; CRL-7790
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7790; true.
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HT-78
AC CVCL_9709
RX PubMed=1320624;
CC From: Van Valen F.; University of Munster; Germany.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9710 ! HT-M1-78
SX Male
CA Cancer cell line
//
ID HT-800.T
AC CVCL_S255
SY HT 800.T
DR ATCC; CRL-7791
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7791; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Undefined cell line type
//
ID HT-801.T
AC CVCL_S398
SY HT 801.T
DR ATCC; CRL-7792
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7792; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Undefined cell line type
//
ID HT-804.Ut
AC CVCL_S399
SY HT 804.Ut
DR ATCC; CRL-7793
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7793; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HT-805.Ut
AC CVCL_S400
SY HT 805.Ut
DR ATCC; CRL-7794
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7794; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HT-806.Ut
AC CVCL_S302
SY HT 806.Ut
DR ATCC; CRL-7795
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7795; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HT-824.Pe
AC CVCL_N464
SY HT 824.Pe
DR ATCC; CRL-7796
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7796; true.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Undefined cell line type
//
ID HT-M1-78
AC CVCL_9710
RX PubMed=1320624;
CC From: Van Valen F.; University of Munster; Germany.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9709 ! HT-78
SX Male
CA Cancer cell line
//
ID HT-STAR
AC CVCL_AR54
DR ECACC; 04072122
RX PubMed=12679787;
CC Group: Retrovirus packaging cell line.
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID HT-STAR-A
AC CVCL_AR55
DR ECACC; 04072123
CC Group: Retrovirus packaging cell line.
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AR54 ! HT-STAR
SX Male
CA Cancer cell line
//
ID HT100
AC CVCL_2953
SY HT-100; HT-100-A
DR JCRB; JCRB0221
RX PubMed=5144528;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Male
CA Cancer cell line
//
ID HT1080 FUS-DDIT3-EGFP
AC CVCL_AX37
RX PubMed=16651630;
RX PubMed=25393000;
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
CC Transfected with: HGNC; 2726; DDIT3 (FUS-DDIT3 fusion).
CC Transfected with: HGNC; 4010; FUS (FUS-DDIT3 fusion).
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID HT1080-luc2
AC CVCL_L898
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 128092.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID HT1080-Red-FLuc
AC CVCL_5I99
SY HT1080 Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW128092
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID HT1080/DR4
AC CVCL_6C48
RX PubMed=1673331;
RX PubMed=1976136;
RX PubMed=2896069;
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID HT115
AC CVCL_2520
SY HT-115; HT 115
DR BTO; BTO:0003460
DR CLO; CLO_0004277
DR EFO; EFO_0006442
DR CLDB; cl1756
DR BioSample; SAMN03472979
DR CCLE; HT115_LARGE_INTESTINE
DR Cosmic; 1609486
DR Cosmic; 2301987
DR Cosmic-CLP; 907289
DR ECACC; 85061104
DR GDSC; 907289
DR GEO; GSM827330
DR GEO; GSM887137
DR GEO; GSM888208
DR GEO; GSM1346843
DR GEO; GSM1448111
DR GEO; GSM1669909
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HT115
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053); Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 7,12
ST D13S317: 13
ST D16S539: 10
ST D18S51: 12,15
ST D21S11: 30,32.2
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 19,20
ST Penta D: 12
ST Penta E: 11,12
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HT145
AC CVCL_W846
SY HTLA145
RX PubMed=2253237;
RX PubMed=3297309;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C834 ! HT161
OI CVCL_W847 ! HT195
CA Cancer cell line
//
ID HT161
AC CVCL_C834
SY HTLA161; Ht161; HT-161
DR Cosmic; 931915
DR Cosmic; 1070845
RX PubMed=2253237;
RX PubMed=3297309;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W846 ! HT145
OI CVCL_W847 ! HT195
CA Cancer cell line
//
ID HT168
AC CVCL_2H38
SY HT-168
DR BTO; BTO:0005041
RX PubMed=2203689;
RX PubMed=11448059;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1059 ! A2058
SX Male
CA Cancer cell line
//
ID HT168-M1
AC CVCL_2H39
SY M1
DR BTO; BTO:0005043
RX PubMed=2203689;
RX PubMed=11448059;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2H38 ! HT168
SX Male
CA Cancer cell line
//
ID HT195
AC CVCL_W847
SY HTLA195
RX PubMed=2253237;
RX PubMed=3297309;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W846 ! HT145
OI CVCL_C834 ! HT161
CA Cancer cell line
//
ID HT2
AC CVCL_AS20
DR TKG; TKG 0716
RX PubMed=17660709;
CC Monoclonal antibody target: UniProtKB; Q15011; Human HERPUD1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID HT22
AC CVCL_0321
SY HT-22
DR BTO; BTO:0003037
DR MCCL; MCC:0000214
DR ChEMBL-Cells; CHEMBL3307590
DR ChEMBL-Targets; CHEMBL614316
DR Lonza; 248
DR PRIDE; PXD001597
RX PubMed=7953717;
RX PubMed=9292733;
RX PubMed=19135458;
RX PubMed=26227174;
WW http://salkinnovations.testtechnologypublisher.com/technology/7060
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-569.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Omics: Secretome proteome analysis.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_U378 ! HT4
CA Transformed cell line
//
ID HT29 gluc C1
AC CVCL_0322
SY HT29glucC1
DR CLO; CLO_0004284
DR MCCL; MCC:0000215
DR CLDB; cl1757
DR Cosmic; 1609500
DR ECACC; 92012401
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5941 ! HT29-18-C1
SX Female
CA Cancer cell line
//
ID HT29 LM1
AC CVCL_5U94
RX PubMed=24823486;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT29 LM2
AC CVCL_5U95
RX PubMed=24823486;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5U94 ! HT29 LM1
SX Female
CA Cancer cell line
//
ID HT29 LM3
AC CVCL_5U96
RX PubMed=24823486;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5U95 ! HT29 LM2
SX Female
CA Cancer cell line
//
ID HT29-12B
AC CVCL_C764
SY HT29 cl.12B; HT29 clone 12B
RX PubMed=6744312;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT29-13G
AC CVCL_C765
SY HT29 cl.13G; HT29 clone 13G
RX PubMed=6744312;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT29-16E
AC CVCL_C763
SY HT29 16E; HT-29 16E; HT29-Cl.16E; HT29 clone 16E
RX PubMed=6744312;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT29-18
AC CVCL_5940
RX PubMed=3611191;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT29-18-C1
AC CVCL_5941
SY HT29-18C1; HT29-18C(1)
RX PubMed=3611191;
RX PubMed=8932439;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5940 ! HT29-18
SX Female
CA Cancer cell line
//
ID HT29-18-N2
AC CVCL_5942
SY HT29-18N2
RX PubMed=3611191;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5940 ! HT29-18
SX Female
CA Cancer cell line
//
ID HT29-18A
AC CVCL_C766
SY HT29 cl.18A; HT29 clone 18A
RX PubMed=6744312;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5940 ! HT29-18
SX Female
CA Cancer cell line
//
ID HT29-19A
AC CVCL_0323
SY HT2919A; HT 29/19A; HT29/19A; HT29 cl.19A; HT29-cl19A; HT29 CL19A; HT29 cl 19A; HT 29 cl.19A; HT29-Cl.19A; HT-29 clone 19A; HT29 clone 19A
DR MCCL; MCC:0000216
RX PubMed=6744312;
RX PubMed=12508250;
RX PubMed=15463957;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT29-luc2
AC CVCL_5J20
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 124353.
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT29-OxR
AC CVCL_5949
RX PubMed=16857785;
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT29-R
AC CVCL_EQ23
SY HT29R
DR GEO; GSM288501
DR GEO; GSM288502
DR GEO; GSM288536
RX PubMed=17945194;
RX PubMed=18694510;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT29/219
AC CVCL_2521
AS CVCL_6835
SY HT-29/219; HT29219
DR BTO; BTO:0002838
DR CLO; CLO_0004285
DR CLDB; cl1758
DR ECACC; 85061109
DR NCBI_Iran; C154
RX PubMed=17254797;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): ECACC; PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 11,12 (ECACC)
ST CSF1PO: 11 (PubMed=17254797)
ST D13S317: 11,12 (ECACC)
ST D13S317: 11 (PubMed=17254797)
ST D16S539: 11,12
ST D18S51: 13
ST D21S11: 28,30
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 10
ST FGA: 19,21
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT29/L-OHP
AC CVCL_4V74
RX PubMed=26400331;
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HT4
AC CVCL_U378
SY HT-4
RX PubMed=1980069;
RX PubMed=2033646;
WW http://php.med.unsw.edu.au/cellbiology/index.php?title=Cells_-_HT4
CC Characteristics: At the restrictive temperature (39 Celsius) the cells take on properties of differentiated neurons they express neuronal antigens, synthesize NGF mRNA, and secrete biologically active NGF in vitro.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID HT93A
AC CVCL_E331
SY HT-93A; HT-93; HT93
DR Cosmic; 975254
DR Cosmic; 1281317
DR DSMZ; ACC-735
DR TKG; TKG 0703
RX PubMed=9472803;
CC Doubling time: ~50 hours (DSMZ).
ST Source(s): DSMZ; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 9,11
ST D5S818: 10,13
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HTAU
AC CVCL_H238
DR BTO; BTO:0002664
RX PubMed=15048935;
CC Transfected with: HGNC; 6893; MAPT.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B396 ! CN1.4
CA Transformed cell line
//
ID HTBOA
AC CVCL_X939
DR CGH-DB; 378-2
DR CGH-DB; 9353-4
RX PubMed=3259199;
RX PubMed=10457904;
RX PubMed=11330945;
RX PubMed=12417041;
RX PubMed=17671176;
DI NCIt; C4509; Undifferentiated ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HTC
AC CVCL_3382
SY Hepatoma Tissue Culture
DR BTO; BTO:0000607
DR CLO; CLO_0004288
DR CLDB; cl1761
DR CLDB; cl1762
DR CLDB; cl1763
DR CLDB; cl1764
DR BCRJ; 0112
DR ECACC; 93120108
DR ICLC; ATL95006
DR Lonza; 246
RX PubMed=4381784;
CC Breed/subspecies: Buffalo.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID HTC (BUdR)
AC CVCL_7217
DR CLO; CLO_0004289
DR CLDB; cl1765
DR ECACC; 85061110
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: Buffalo.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3382 ! HTC
SX Male
CA Cancer cell line
//
ID HTC-C3
AC CVCL_1295
SY HTC/C3; HTC C3; HTCC3
DR CLO; CLO_0050946
DR BioSample; SAMN01821636
DR BioSample; SAMN01821686
DR BioSample; SAMN03470940
DR CGH-DB; 58-1
DR ChEMBL-Cells; CHEMBL3308747
DR ChEMBL-Targets; CHEMBL1075472
DR Cosmic; 924151
DR Cosmic; 2009524
DR Cosmic; 2054084
DR Cosmic-CLP; 924151
DR DSMZ; ACC-580
DR GDSC; 924151
DR GEO; GSM1669916
DR JCRB; JCRB0164
DR RCB; RCB0452
RX PubMed=2196988;
RX PubMed=9177455;
RX PubMed=16924234;
RX PubMed=23833040;
RX PubMed=27397505;
CC Doubling time: ~100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; DSMZ; JCRB; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 9,12
ST D18S51: 14,17
ST D19S433: 14
ST D21S11: 29,30
ST D2S1338: 17,23
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 12,14
ST FGA: 21,22
ST Penta D: 9
ST Penta E: 11,16
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 14,15
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HTC4
AC CVCL_D053
SY HTC-4; Hepatoma Tissue Culture-4
DR BTO; BTO:0003574
CC Breed/subspecies: Buffalo.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3382 ! HTC
CA Cancer cell line
//
ID hTCEpi
AC CVCL_AQ44
SY human Telomerase-immortalized Corneal Epithelial cell line
RX PubMed=15671271;
WW http://www.evercyte.com/htcepi.html
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID HTD114
AC CVCL_D683
SY HTD-114; HTD 114
DR BTO; BTO:0004315
RX PubMed=6307822;
RX PubMed=7510848;
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID hTERT-1604
AC CVCL_C472
SY 1604hTERT; hTERT-NOR2; hTERT-GM01604; GM1604-hTERT
RX PubMed=10655550;
RX PubMed=11731418;
RX PubMed=12604777;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7325 ! GM01604
SX Male
CA Telomerase immortalized cell line
//
ID HTERT-AEC II
AC CVCL_T048
RX PubMed=24086682;
CC Transfected with: HGNC; 11730; TERT.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
CA Telomerase immortalized cell line
//
ID hTERT-CBECs
AC CVCL_2H44
RX PubMed=26156242;
CC Transfected with: HGNC; 11730; TERT.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Telomerase immortalized cell line
//
ID hTERT-EEC-B37
AC CVCL_X007
SY hTERT-EEC
DR BioSample; SAMN03151839
RX DOI=10.1530/jme.1.01550e;
RX PubMed=15821114;
RX PubMed=22710073;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a MCF-7 derivative (PubMed=22710073).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0031 ! MCF-7
SX Female
CA Cancer cell line
//
ID hTERT-GTCs
AC CVCL_S894
SY hTERT-Goat Trophoblast Cells
RX PubMed=24112823;
CC Doubling time: 26.79 hours (PubMed=24112823).
CC Transfected with: HGNC; 11730; TERT.
CC Breed/subspecies: Saanen.
OX NCBI_TaxID=9925; ! Capra hircus
SX Female
CA Telomerase immortalized cell line
//
ID hTERT-HM
AC CVCL_S888
DR EFO; EFO_0005912
DR ENCODE; ENCBS560ENC
RX PubMed=12135889;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/Myometr_Crawford_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID hTERT-HME1
AC CVCL_3383
SY hTERT-HME-1; hTERTHME1; HME-1; HME1; ME16C
DR CLO; CLO_0004291
DR ATCC; CRL-4010
DR BioSample; SAMN03471718
DR GEO; GSM756369
DR GEO; GSM1008912
DR LINCS; 50056
RX PubMed=19582160;
RX PubMed=24162158;
CC Transfected with: HGNC; 11730; TERT.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 7,12
ST TH01: 7,8
ST TPOX: 10,12
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID hTERT-hOd-1
AC CVCL_0E49
SY hTERT-human Odontoblast-1
RX PubMed=16430186;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID hTERT-HPNE
AC CVCL_C466
DR ATCC; CRL-4023
RX PubMed=12589817;
RX PubMed=17332339;
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID hTERT-HPNE E6/E7
AC CVCL_C467
DR ATCC; CRL-4036
RX PubMed=17332339;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C466 ! hTERT-HPNE
SX Male
CA Transformed cell line
//
ID hTERT-HPNE E6/E7/K-RasG12D
AC CVCL_C469
DR ATCC; CRL-4038
RX PubMed=17332339;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: HGNC; 6407; KRAS (with D-12).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C467 ! hTERT-HPNE E6/E7
SX Male
CA Transformed cell line
//
ID hTERT-HPNE E6/E7/K-RasG12D/st
AC CVCL_C470
DR ATCC; CRL-4039
RX PubMed=17332339;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: HGNC; 6407; KRAS (with D-12).
CC Transfected with: UniProtKB; P17493; S.hindustanus ble.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C469 ! hTERT-HPNE E6/E7/K-RasG12D
SX Male
CA Transformed cell line
//
ID hTERT-HPNE E6/E7/st
AC CVCL_C468
DR ATCC; CRL-4037
RX PubMed=17332339;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P17493; S.hindustanus ble.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C467 ! hTERT-HPNE E6/E7
SX Male
CA Transformed cell line
//
ID hTERT-HSC
AC CVCL_M102
DR BTO; BTO:0003517
RX PubMed=11896211;
RX PubMed=17760834;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID hTERT-RBS
AC CVCL_HE60
SY hTERT-GM03913
RX PubMed=10655550;
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C4681; Hypomelia hypotrichosis facial hemangioma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1K35 ! GM03913
SX Male
CA Telomerase immortalized cell line
//
ID hTERT-RPE1
AC CVCL_4388
SY hTERT RPE1; hTERT-RPE-1; hTERT RPE-1; hTERT-RPE; TERT-RPE1; RPE-1; RPE1; RPE1-hTERT; RPE1-hTert
DR BTO; BTO:0004790
DR ATCC; CRL-4000
DR BioSample; SAMN03472089
DR ChEMBL-Cells; CHEMBL3307755
DR ChEMBL-Targets; CHEMBL615013
DR PRIDE; PXD004915
RX PubMed=9454332;
RX PubMed=11980883;
WW http://www.cellimagelibrary.org/images/35201
WW http://www.immanis.com/TelomeraseImmortalizedCellLineCulturingGuide.pdf
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Deep proteome analysis.
CC Misspelling: Occasionally 'hTERT1-RPE1'.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 14,16
ST D21S11: 31,32.2
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 10
ST FGA: 20,23
ST Penta D: 9,11
ST Penta E: 12,14
ST TH01: 9
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B365 ! RPE-340
SX Female
CA Telomerase immortalized cell line
//
ID hTERT-RPE1/APC15
AC CVCL_5F68
SY hTERT-RPE1 APC15
DR Ximbio; 151710
RX PubMed=21926987;
CC Transfected with: HGNC; 24531; ANAPC15.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4388 ! hTERT-RPE1
SX Female
CA Telomerase immortalized cell line
//
ID hTf18-10C/sf
AC CVCL_4W45
DR JCRB; JCRB1611
CC Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID hTf2-9F
AC CVCL_4W46
DR JCRB; JCRB1504
CC Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID hTf26-9B
AC CVCL_4W47
DR JCRB; JCRB1613
CC Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID hTf30-8H
AC CVCL_4W48
DR JCRB; JCRB1599
CC Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID hTf30-8H/sf
AC CVCL_4W49
DR JCRB; JCRB1602
CC Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4W48 ! hTf30-8H
CA Hybridoma
//
ID hTf9-11E
AC CVCL_4W50
DR JCRB; JCRB1617
CC Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID HTG-1
AC CVCL_5G09
SY HTG1
RX Patent=US20140057801;
RX PubMed=21900896;
CC Group: Haploid karyotype cell line.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID HTG-2
AC CVCL_5G10
SY HTG2
RX Patent=US20140057801;
RX PubMed=21900896;
CC Group: Haploid karyotype cell line.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID HTh104
AC CVCL_A427
AS CVCL_6477
SY HTh 104; HTh-104; Uhth-104; U-Hth104; U-hth104
DR Cosmic; 1068620
DR Cosmic; 1239962
DR Cosmic; 2054083
DR Cosmic; 2050370
RX PubMed=17465858;
RX PubMed=18713817;
RX PubMed=21868764;
RX PubMed=23833040;
ST Source(s): PubMed=18713817; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 8,9,12
ST D18S51: 14,19
ST D21S11: 27,31.2
ST D3S1358: 14
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 12,13
ST FGA: 23
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HTh112
AC CVCL_A428
SY HTh 112; HTh-112; Uhth-112; U-hth112; U-Hth112
DR Cosmic; 1068621
DR Cosmic; 1239972
DR Cosmic; 2050369
RX PubMed=17465858;
RX PubMed=21868764;
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 6
ST TPOX: 8,9
ST vWA: 19
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HTh7
AC CVCL_6289
SY Hth7; HTh 7; HTh-7; Uhth-7; U-hth7; U-Hth7
DR BTO; BTO:0005146
DR Cosmic; 1068622
DR Cosmic; 1239969
DR Cosmic; 1280043
DR Cosmic; 1507376
DR Cosmic; 1533553
DR Cosmic; 1536129
DR Cosmic; 1889008
DR Cosmic; 2050367
DR Cosmic; 2054111
DR Cosmic; 2319851
RX PubMed=17465858;
RX PubMed=18713817;
RX PubMed=21868764;
RX PubMed=23833040;
ST Source(s): PubMed=18713817; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,14
ST D16S539: 9,13
ST D18S51: 16
ST D21S11: 29,30
ST D3S1358: 14,15
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 12,13
ST FGA: 20,23
ST TH01: 9,9.3
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HTh74
AC CVCL_6288
SY Hth74; HTh 74; HTh-74; Uhth-74; U-hth74
DR BTO; BTO:0005147
DR Cosmic; 889490
DR Cosmic; 1068623
DR Cosmic; 1084284
DR Cosmic; 1132594
DR Cosmic; 1152119
DR Cosmic; 1239982
DR Cosmic; 1280050
DR Cosmic; 1507377
DR Cosmic; 1533554
DR Cosmic; 1536130
DR Cosmic; 1889009
DR Cosmic; 2036690
DR Cosmic; 2050368
DR Cosmic; 2054102
DR Cosmic; 2319855
RX PubMed=1655394;
RX PubMed=1726925;
RX PubMed=17465858;
RX PubMed=17725429;
RX PubMed=18713817;
RX PubMed=19087340;
RX PubMed=23833040;
CC Misspelling: 'Hth47' in Cosmic 889490.
ST Source(s): PubMed=18713817
ST Amelogenin: X
ST D13S317: 12,13
ST D18S51: 14
ST D21S11: 32
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8,9
ST D8S1179: 13,15,16
ST FGA: 25
ST vWA: 17,19
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HTh74 clone 7
AC CVCL_AT82
SY HTh-74 clone7; U-Hth74-clone7
RX PubMed=21868764;
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 8,9
ST TH01: 8,9
ST TPOX: 11
ST vWA: 17,19
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6288 ! HTh74
SX Female
CA Cancer cell line
//
ID HTh83
AC CVCL_0046
SY Hth83; HTh 83; HTh-83; hth83; U-Hth83
DR BTO; BTO:0005148
DR Cosmic; 1068624
DR Cosmic; 1152120
DR Cosmic; 1239973
DR Cosmic; 2054092
RX PubMed=10918212;
RX PubMed=17465858;
RX PubMed=21868764;
RX PubMed=23833040;
WW http://www.proteinatlas.org/learn/cellines
CC Omics: Deep antibody staining analysis.
CC Omics: Deep RNAseq analysis.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 12
ST TH01: 6,9
ST TPOX: 8
ST vWA: 19
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HTHCL-PI 47
AC CVCL_9V81
DR NCBI_Iran; C478
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9V82 ! HHCL-PI 48
SX Male
CA Transformed cell line
//
ID HTk
AC CVCL_9W65
RX PubMed=12429219;
RX PubMed=16646156;
CC Transformant: Unknown product of UCHT1 (CVCL_9W35) conditioned media.
CC Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
DI NCIt; C125660; Mouse trisomy 16
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID HTK-
AC CVCL_2522
DR CLO; CLO_0004292
DR CLDB; cl1766
DR CCLE; HTK_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ECACC; 88022409
DR GEO; GSM888214
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Caution: Could be identical to 143B (CVCL_2270).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 10,13
ST D5S818: 13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 11
ST vWA: 18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HTLA230
AC CVCL_8881
SY HTLA-230
DR BioSample; SAMN04459501
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=1568793;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-563.html
CC Derived from metastatic site: Bone marrow.
ST Source(s): BioSample=SAMN04459501
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,14
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 11
ST vWA: 16,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HTLC
AC CVCL_R876
RX CelloPub=CLPUB00053;
CC Group: Fish cell line.
OX NCBI_TaxID=244447; ! Cynoglossus semilaevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID HTLS
AC CVCL_W385
RX PubMed=16130899;
DI NCIt; C3194; Liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HTM-2
AC CVCL_5G31
SY HTM2; Human Trabecular Meshwork-2
RX PubMed=1607235;
RX PubMed=8156826;
DI NCIt; C26782; Glaucoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HTM-4
AC CVCL_5G32
SY HTM4; Human Trabecular Meshwork-4
RX PubMed=1607235;
RX PubMed=8156826;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HTMM
AC CVCL_8720
DR CLO; CLO_0050076
DR BioSample; SAMN03472221
DR RCB; RCB0700
CC Derived from metastatic site: Lymph node.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 10
ST D5S818: 13
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HTMMT
AC CVCL_8721
DR CLO; CLO_0050882
DR BioSample; SAMN03472266
DR RCB; RCB0660
RX PubMed=15859158;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,13
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HTOA
AC CVCL_5457
DR CLO; CLO_0051442
DR BioSample; SAMN03472217
DR CGH-DB; 342-2
DR CGH-DB; 9351-4
DR Cosmic; 931366
DR RCB; RCB0692
RX PubMed=2435620;
RX PubMed=11330945;
RX PubMed=12417041;
RX PubMed=17671176;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,10
ST D16S539: 9,13
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 7
ST TPOX: 11
ST vWA: 17
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HTOG
AC CVCL_6656
RX PubMed=6323807;
RX PubMed=15541573;
DI NCIt; C6261; Ovarian granulosa cell tumor
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6657 ! HTOT
SX Female
CA Cancer cell line
//
ID HTori-3
AC CVCL_4W02
SY HTori:3; HTori 3; HTori3
RX PubMed=2557880;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HTOT
AC CVCL_6657
RX PubMed=6323807;
DI NCIt; C6261; Ovarian granulosa cell tumor
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6656 ! HTOG
SX Female
CA Cancer cell line
//
ID HTOXAR3
AC CVCL_8476
SY HTOXAR-3
DR BTO; BTO:0005026
RX PubMed=16773204;
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID htr-20
AC CVCL_U031
DR ECACC; 10080903
RX PubMed=2158104;
CC Monoclonal antibody target: UniProtKB; P19438; Human TNFRSF1A/CD120a.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID HTR-8
AC CVCL_D728
SY HTR8
RX PubMed=7684692;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Finite cell line
//
ID HTR-8/SVneo
AC CVCL_7162
SY HTR-8/SV neo; HTR-8/SV-neo; HTR8/SVneo; HTR8svn
DR BTO; BTO:0004125
DR EFO; EFO_0005709
DR ATCC; CRL-3271
DR ENCODE; ENCBS331AAA
DR GEO; GSM816644
DR TOKU-E; 4099
RX PubMed=7684692;
RX PubMed=23325432;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/HTR8svn_Crawford_protocol.pdf
WW http://www.sonidel.com/sonidel/electroporation/nepa21-electroporator/cell-lines-htr-8-svneo-human-trophoblast-cells/
CC Part of: ENCODE project common cell types; tier 3.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Omics: DNA methylation analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 13
ST D5S818: 12
ST D7S820: 12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 13,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D728 ! HTR-8
SX Sex undetermined
CA Transformed cell line
//
ID htr-9c
AC CVCL_U032
DR ECACC; 10080902
RX PubMed=2158104;
CC Monoclonal antibody target: UniProtKB; P19438; Human TNFRSF1A/CD120a.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID HTST
AC CVCL_8722
DR CLO; CLO_0050139
DR BioSample; SAMN03472191
DR RCB; RCB0967
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 7,12
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 12
ST TH01: 9
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C99055; Sacrococcygeal teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HtTA-1
AC CVCL_2523
SY HtTA1
DR CLO; CLO_0004293
DR CLDB; cl1767
DR ECACC; 95091410
RX PubMed=1319065;
CC Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HTUD1
AC CVCL_L695
DR RCB; RCB0713
CC Group: Amphibian cell line.
OX NCBI_TaxID=324344; ! Hynobius tokyoensis
SX Female
CA Spontaneously immortalized cell line
//
ID HTZ-19 dM
AC CVCL_IS45
SY HTZ 19-dM; HTZ-19
RX PubMed=2208165;
RX PubMed=2766302;
CC Derived from metastatic site: Central nervous system.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HTZ17XP
AC CVCL_3721
SY HTZ17BE
DR CLO; CLO_0004294
DR ATCC; CRL-1361
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M998 ! GM02473
SX Female
CA Finite cell line
//
ID Hu 126
AC CVCL_U699
DR ATCC; CRL-1246
CC Discontinued: ATCC; CRL-1246; true.
DI NCIt; C36529; Trisomy 13
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HU 214
AC CVCL_W443
SY Hu 214; HU-214
RX PubMed=3368969;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HU-01
AC CVCL_HE65
DR ATCC; CRL-10249
RX Patent=US5128259;
CC Characteristics: CSF2 dependent.
DI NCIt; C3170; Acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HU-3
AC CVCL_A619
DR Cosmic; 787436
DR Cosmic; 975255
DR Cosmic; 1012070
DR Cosmic; 1281318
DR Cosmic; 2306210
RX PubMed=9406997;
RX PubMed=16408098;
DI NCIt; C7965; Adult acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HU-E
AC CVCL_0C14
RX PubMed=7736387;
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hu1125
AC CVCL_8449
SY Hu 1125; HU 1125
RX PubMed=7262169;
RX PubMed=7905254;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID Hu1694
AC CVCL_8450
SY Hu 1694
RX PubMed=7905254;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID Hu1703He
AC CVCL_8236
SY Hu 1703He; HU 1703 He
RX PubMed=3800330;
RX PubMed=8105864;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Undefined cell line type
//
ID Hu1734
AC CVCL_8451
SY Hu 1734; HU 1734
DR BioSample; SAMN03151654
RX PubMed=7905254;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HCV-29 derivative (PubMed=7905254, PubMed=20143388).
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8228 ! HCV-29
CA Cancer cell line
//
ID Hu1752
AC CVCL_8452
SY Hu 1752; HU 1752
RX PubMed=7905254;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID Hu1922
AC CVCL_8237
SY Hu 1922; HU 1922
RX PubMed=3800330;
RX PubMed=8105864;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hu44
AC CVCL_DD90
DR ATCC; HB-8576
RX Patent=US4695538;
CC Discontinued: ATCC; HB-8576; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8119 ! HMy.2 B
CA Hybridoma
//
ID Hu456
AC CVCL_8238
SY Hu 456; HU 456; HU456
DR BioSample; SAMN03151943
DR Cosmic; 925829
DR Cosmic; 2037947
DR GEO; GSM1574544
RX PubMed=3708594;
RX PubMed=6546195;
RX PubMed=6826254;
RX PubMed=7262169;
RX PubMed=8105864;
RX PubMed=20143388;
RX PubMed=24018021;
RX PubMed=25997541;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=3708594, PubMed=8105864, PubMed=20143388).
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 16,18
ST D21S11: 29
ST D8S1179: 14
ST FGA: 22
ST TH01: 6
ST vWA: 17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID Hu5/E18
AC CVCL_U895
SY E18
DR BioSample; SAMN03471917
DR RCB; RCB2366
RX PubMed=16919240;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,12
ST D16S539: 9,10
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Hu549
AC CVCL_8239
SY Hu 549; HU 549
DR BioSample; SAMN03151944
RX PubMed=7262169;
RX PubMed=8105864;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=8105864, PubMed=20143388).
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID Hu564
AC CVCL_8453
SY Hu 564
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hu609
AC CVCL_8240
SY HU609; Hu 609; HU 609
DR BioSample; SAMN03151802
DR Lonza; 245
RX PubMed=3708594;
RX PubMed=3800330;
RX PubMed=6546195;
RX PubMed=7262169;
RX PubMed=7905254;
RX PubMed=8105864;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a J82 derivative (PubMed=7905254, PubMed=20143388).
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 10,12
ST D21S11: 30,31
ST D8S1179: 8,13
ST FGA: 20,24
ST TH01: 9.3
ST vWA: 17,18
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0359 ! J82
SX Male
CA Cancer cell line
//
ID Hu609T
AC CVCL_8241
SY Hu 609T; HU 609 T
RX PubMed=6546195;
RX PubMed=7262169;
RX PubMed=8105864;
CC Problematic cell line: Contaminated. Parent cell line (Hu609) has been shown to be a J82 derivative.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8240 ! Hu609
SX Male
CA Cancer cell line
//
ID Hu609Tmv
AC CVCL_8242
DR BioSample; SAMN03151945
RX PubMed=8105864;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=8105864, PubMed=20143388).
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID Hu961a
AC CVCL_8243
SY Hu 961a; Hu961t; HU961T
DR BioSample; SAMN03151946
DR Cosmic; 925830
RX PubMed=3708594;
RX PubMed=8105864;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=3708594, PubMed=8105864, PubMed=20143388).
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 16,18
ST D21S11: 29
ST D8S1179: 14
ST FGA: 22
ST TH01: 6
ST vWA: 17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID Hu961b
AC CVCL_8244
SY Hu 961b; HU 961b
RX PubMed=3800330;
RX PubMed=7905254;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HUB-41
AC CVCL_M875
SY HUB41
RX PubMed=2607719;
RX PubMed=7474403;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HUBT-n
AC CVCL_S812
RX PubMed=16130901;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HUC-F
AC CVCL_4684
DR CLO; CLO_0050430
DR BioSample; SAMN03472336
DR RCB; RCB0153
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,11
ST D16S539: 9
ST D5S818: 10
ST D7S820: 11,13
ST TH01: 8,9
ST TPOX: 8,9
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HUC-F2
AC CVCL_4682
DR CLO; CLO_0050429
DR BioSample; SAMN03472309
DR RCB; RCB0436
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 11
ST D7S820: 10
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HUC-Fm
AC CVCL_2524
DR CLO; CLO_0004295
DR CLO; CLO_0050431
DR CLDB; cl1768
DR BioSample; SAMN03472344
DR ECACC; 87100801
DR RCB; RCB0197
ST Source(s): ECACC; RCB
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 11,12
ST D16S539: 10,11
ST D5S818: 11,14
ST D7S820: 8,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HUC-Fm2
AC CVCL_4683
DR CLO; CLO_0050432
DR BioSample; SAMN03472310
DR RCB; RCB0437
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,10
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 8,12
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HUCB-NSC
AC CVCL_EG09
SY HUCB-NSCs; Human Umbilical Cord Blood-Neural Stem Cells
RX PubMed=16846376;
RX PubMed=16909032;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID HuCC-A1
AC CVCL_M255
SY HuCCA-1; HuCCA1
RX CelloPub=CLPUB00275;
RX PubMed=1666951;
RX PubMed=9031402;
RX PubMed=15048994;
RX PubMed=20069059;
WW http://www2.cri.or.th/lab/biochemistry/res_act
CC Doubling time: ~55 hours (PubMed=1666951).
CC Omics: Secretome proteome analysis.
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HuCC-A1Nu
AC CVCL_HF36
SY HuCCA-1Nu
RX PubMed=9031402;
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M255 ! HuCC-A1
SX Male
CA Cancer cell line
//
ID HuCC-T1
AC CVCL_0324
SY HuCCT-1; HUCCT-1; HUCC-T1; HUCCT1; HuCCT1
DR BTO; BTO:0003911
DR CLO; CLO_0050009
DR MCCL; MCC:0000217
DR BioSample; SAMN01821687
DR BioSample; SAMN03470954
DR BioSample; SAMN03471627
DR CCLE; HUCCT1_BILIARY_TRACT
DR ChEMBL-Cells; CHEMBL3307409
DR ChEMBL-Targets; CHEMBL614581
DR Cosmic; 907069
DR Cosmic; 1122350
DR Cosmic; 1571782
DR Cosmic; 2009540
DR Cosmic-CLP; 907069
DR GDSC; 907069
DR GEO; GSM827224
DR GEO; GSM887144
DR GEO; GSM888216
DR GEO; GSM1669917
DR JCRB; JCRB0425
DR RCB; RCB1960
DR TKG; TKG 0389
RX CelloPub=CLPUB00275;
RX PubMed=2544546;
RX PubMed=9290701;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 11,12 (Cosmic-CLP; JCRB; RCB; TKG)
ST D16S539: 9,11,12 (PubMed=25877200)
ST D18S51: 13
ST D19S433: 13
ST D21S11: 31
ST D2S1338: 17,18
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 10
ST FGA: 20,23
ST Penta D: 10
ST Penta E: 15,18
ST TH01: 7,10
ST TPOX: 8
ST vWA: 18
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HUCL-1
AC CVCL_0J48
RX PubMed=6170720;
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3622 ! WEHI-3
CA Cancer cell line
//
ID HUEhT-1
AC CVCL_4W51
SY hT-1
DR JCRB; JCRB1458
RX PubMed=17207773;
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4W52 ! HUEhT-2
SX Female
CA Telomerase immortalized cell line
//
ID HUEhT-2
AC CVCL_4W52
SY hT-2
DR JCRB; JCRB1459
RX PubMed=17207773;
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4W51 ! HUEhT-1
SX Female
CA Telomerase immortalized cell line
//
ID HUES 1
AC CVCL_B139
SY HUES-1; HUES1; HuES1; Hues1; HVRDe001-A
DR EFO; EFO_0005355
DR ENCODE; ENCBS771TSF
DR ENCODE; ENCBS790PAZ
DR hPSCreg; HVRDe001-A
DR ISCR; 102
RX PubMed=14999088;
RX PubMed=17572666;
RX PubMed=21714037;
WW http://harvard.eagle-i.net/i/00000140-2baf-4e23-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=32
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0014.
CC Registration: Swiss research registry; BAG-hES-IMP-0035.
CC Registration: UK Stem Cell Bank (UKSCB); R-05-033, Steering comm. appl. SCSC04-25(1).
CC Doubling time: 24 hours (PubMed=14999088).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 10
AC CVCL_B140
SY HUES-10; HuES10; HVRDe010-A
DR hPSCreg; HVRDe010-A
DR ISCR; 111
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2bcb-ca08-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=41
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0023.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-010, Steering comm. appl. SCSC04-25(10).
CC Doubling time: 72 hours (PubMed=14999088).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 11
AC CVCL_B141
SY HUES-11; HuES11; HVRDe011-A
DR hPSCreg; HVRDe011-A
DR ISCR; 112
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2bcc-805f-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=42
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0024.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-011, Steering comm. appl. SCSC04-25(11).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 12
AC CVCL_B142
SY HUES-12; HuES12; Hues12; HVRDe012-A
DR hPSCreg; HVRDe012-A
DR ISCR; 113
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2bcd-0ee1-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=43
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0025.
CC Registration: Swiss research registry; BAG-hES-IMP-0040.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-012, Steering comm. appl. SCSC04-25(12).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 13
AC CVCL_B143
SY HUES-13; HuES13; Hues13; HVRDe013-A
DR EFO; EFO_0007078
DR ENCODE; ENCBS429TAI
DR GEO; GSM670087
DR hPSCreg; HVRDe013-A
DR ISCR; 114
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2bcd-8f54-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=44
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0026.
CC Registration: Swiss research registry; BAG-hES-IMP-0041.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-013, Steering comm. appl. SCSC04-25(13).
CC Doubling time: 24 hours (PubMed=14999088).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 14
AC CVCL_B144
SY HUES-14; HuES14; Hues14; HVRDe014-A
DR hPSCreg; HVRDe014-A
DR ISCR; 115
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2bce-138e-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=45
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0027.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-014, Steering comm. appl. SCSC04-25(14).
CC Doubling time: 48 hours (PubMed=14999088).
CC Miscellaneous: Sibling to HUES 15 (CVCL_B145).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 15
AC CVCL_B145
SY HUES-15; HuES15; HVRDe015-A
DR hPSCreg; HVRDe015-A
DR ISCR; 116
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2bce-9d34-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=46
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0028.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-015, Steering comm. appl. SCSC04-25(15).
CC Doubling time: 48 hours (PubMed=14999088).
CC Miscellaneous: Sibling to HUES 14 (CVCL_B144).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 16
AC CVCL_B146
SY HUES-16; HuES16; Hues16; HVRDe016-A
DR hPSCreg; HVRDe016-A
DR ISCR; 117
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2bcf-2c00-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=47
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0029.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-016, Steering comm. appl. SCSC04-25(16).
CC Doubling time: 48 hours (PubMed=14999088).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 17
AC CVCL_B147
SY HUES-17; HuES17; HVRDe017-A
DR hPSCreg; HVRDe017-A
DR ISCR; 118
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2bd2-8127-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=48
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0030.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-017, Steering comm. appl. SCSC04-25(17).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 18
AC CVCL_B148
DR ISCR; 601
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2bd2-f0f5-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=49
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0031.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 19
AC CVCL_B149
DR ISCR; 602
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2bd3-6260-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=50
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0032.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 2
AC CVCL_B150
SY HUES-2; HuES2; HVRDe002-A
DR hPSCreg; HVRDe002-A
DR ISCR; 103
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2fd0-4695-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=33
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0015.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-006, Steering comm. appl. SCSC04-25(2).
CC Doubling time: 24 hours (PubMed=14999088).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 20
AC CVCL_B151
DR ISCR; 603
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd0-c4cb-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=51
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0033.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 21
AC CVCL_B152
DR ISCR; 604
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd1-35fe-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=52
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0034.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 22
AC CVCL_B153
DR ISCR; 605
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd1-b543-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=53
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0035.
CC Miscellaneous: Sibling to HUES 23 (CVCL_B154).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 23
AC CVCL_B154
DR ISCR; 606
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd2-1eb2-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=54
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0036.
CC Miscellaneous: Sibling to HUES 22 (CVCL_B153).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 24
AC CVCL_B155
DR ISCR; 607
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd2-8b04-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=55
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0037.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 25
AC CVCL_B156
SY HUES25
DR ISCR; 608
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ecd-3b72-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/not_approved.htm
CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID HUES 26
AC CVCL_B157
DR ISCR; 609
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd2-ec95-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=57
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0038.
CC Miscellaneous: Sibling to HUES 27 (CVCL_B158).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 27
AC CVCL_B158
DR ISCR; 610
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd3-54a7-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=58
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0039.
CC Miscellaneous: Sibling to HUES 26 (CVCL_B157).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 28
AC CVCL_B159
SY HUES28
DR EFO; EFO_0007079
DR ENCODE; ENCBS356KHC
DR ISCR; 611
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd3-b164-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=59
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0040.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 29
AC CVCL_B160
DR ISCR; 612
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed0-ec80-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 3
AC CVCL_B161
SY HUES-3; HuES-3; HUES3; HuES3; Hues3; HVRDe003-A
DR EFO; EFO_0007080
DR ENCODE; ENCBS433HCT
DR GEO; GSM621767
DR GEO; GSM670075
DR hPSCreg; HVRDe003-A
DR ISCR; 104
RX PubMed=14999088;
RX PubMed=17572666;
RX PubMed=22514597;
WW http://harvard.eagle-i.net/i/00000140-2fd4-40c4-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=34
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0016.
CC Registration: Swiss research registry; BAG-hES-IMP-0036.
CC Registration: UK Stem Cell Bank (UKSCB); R-05-034, Steering comm. appl. SCSC04-25(3).
CC Doubling time: 60 hours (PubMed=14999088).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 3 Hb9::GFP
AC CVCL_X724
SY HUES 3 HB9::GFP; HuES 3 Hb9::GFP; HuES-3 Hb9::GFP; HUES3 Hb9::GFP
RX PubMed=19041780;
WW http://discovery.lifemapsc.com/stem-cell-differentiation/in-vitro-cells/inner-cell-mass-homo-sapiens-hb9-gfp-genetically-modified-stem-cells-harvard-university
CC From: Harvard University; Boston; USA.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B161 ! HUES 3
SX Male
CA Embryonic stem cell
//
ID HUES 30
AC CVCL_B162
DR ISCR; 613
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed4-7229-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 31
AC CVCL_B163
DR ISCR; 614
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed5-9311-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 32
AC CVCL_B164
DR ISCR; 615
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed6-1d81-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 33
AC CVCL_B165
DR ISCR; 616
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed6-89cc-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 34
AC CVCL_B166
DR ISCR; 617
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed7-0060-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 35
AC CVCL_B167
DR ISCR; 618
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed7-798c-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 36
AC CVCL_B168
DR ISCR; 619
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed8-002f-a870-ad6980000000
CC From: Harvard University; Boston; USA.
CC Miscellaneous: Sibling to HUES 37 (CVCL_B169), HUES 38 (CVCL_B170) and HUES 39 (CVCL_B171).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 37
AC CVCL_B169
DR ISCR; 620
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed8-8cd5-a870-ad6980000000
CC From: Harvard University; Boston; USA.
CC Miscellaneous: Sibling to HUES 36 (CVCL_B168), HUES 38 (CVCL_B170) and HUES 39 (CVCL_B171).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 38
AC CVCL_B170
DR ISCR; 621
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed8-fe29-a870-ad6980000000
CC From: Harvard University; Boston; USA.
CC Miscellaneous: Sibling to HUES 36 (CVCL_B168), HUES 37 (CVCL_B169) and HUES 39 (CVCL_B171).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 39
AC CVCL_B171
DR ISCR; 622
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ed9-5d28-a870-ad6980000000
CC From: Harvard University; Boston; USA.
CC Miscellaneous: Sibling to HUES 36 (CVCL_B168), HUES 37 (CVCL_B169) and HUES 38 (CVCL_B170).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 4
AC CVCL_B172
SY HUES-4; HUES4; HuES4; HVRDe004-A
DR hPSCreg; HVRDe004-A
DR ISCR; 105
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2fd4-aa92-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=35
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0017.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-007, Steering comm. appl. SCSC04-25(4).
CC Doubling time: 48 hours (PubMed=14999088).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
- 公告/新闻
